Skip to Content

International Journal of Neonatal Screening, Volume 8, Issue 1

2022 March - 22 articles

Cover Story: In the wake of the addition of mucopolysaccharidosis type II (MPS-II) to the recommended uniform screening panel (RUSP) for state newborn screening (NBS) programs, this study compares two highly relevant methods for measuring glycosaminoglycan (GAG) biomarkers of MPS-II. Data from rare MPS-II newborn DBS are reported. This study also reports GAG biomarker levels in newborn DBS identified as false positives in the first-tier enzyme assay by Illinois State NBS laboratories. In the last four years, global population screenings have suggested that the inclusion of a second-tier GAG biomarker method for MPS-II would dramatically decrease false positives from the first-tier enzyme assay. The data from these false positives further support the value of second-tier biomarker screening. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles

There are no articles in this issue yet.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Int. J. Neonatal Screen. - ISSN 2409-515X